Current Report Filing (8-k)
March 29 2016 - 7:06AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
March 29, 2016
Date of Report (Date of Earliest Event
Reported)
IntelGenx Technologies Corp.
(Exact Name of Registrant as Specified in its Charter)
Delaware
|
000-31187
|
870638336
|
(State or other jurisdiction of
|
(Commission File
|
(IRS Employer Identification
|
incorporation)
|
Number)
|
No.)
|
6420 Abrams, Ville St- Laurent, Quebec, Canada H4S
1Y2
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (514)
331-7440
Check the appropriate box below if the Form 8K fining is
intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
[ ] Written communications pursuant to Rule
425 under the Securities Act (17CFR230.425)
[ ] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
[ ] Pre-commencement communication pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events - News Release
IntelGenx and RedHill Biopharma Announce RIZAPORT
Commercialization Term Sheet with Grupo Juste for Spain and Additional Potential
Territories
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
INTELGENX TECHNOLOGIES CORP.
Dated: March 29, 2016
|
By:
|
/s/
Horst G. Zerbe
|
|
|
Horst G. Zerbe
|
|
|
President and Chief Executive Officer
|
IntelGenx Technologies (CE) (USOTC:IGXT)
Historical Stock Chart
From Aug 2024 to Sep 2024
IntelGenx Technologies (CE) (USOTC:IGXT)
Historical Stock Chart
From Sep 2023 to Sep 2024